Bioequivalence Study of Different Aprocitentan Tablet Formulations
NCT05196399
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
Aprocitentan (Formulation A)
DRUG:
Aprocitentan (Formulation B)
Sponsor
Idorsia Pharmaceuticals Ltd.